Eagle Pharmaceuticals, Inc. financial data

Symbol
EGRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q/A - Q2 2023 - Aug 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181 % -22.7%
Quick Ratio 47.5 % +39.2%
Debt-to-equity 67.8 % +39.6%
Return On Equity 4.98 % -55.5%
Return On Assets 2.97 % -60.6%
Operating Margin 15.9 % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13M shares -2.24%
Entity Public Float 413M USD -5.62%
Common Stock, Value, Issued 18K USD 0%
Weighted Average Number of Shares Outstanding, Basic 13.1M shares +1.99%
Weighted Average Number of Shares Outstanding, Diluted 13.2M shares +2.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 258M USD -5.38%
Research and Development Expense 35.6M USD -20.1%
Costs and Expenses 217M USD +0.99%
Operating Income (Loss) 41M USD -29%
Nonoperating Income (Expense) -11.8M USD +32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 29.2M USD -27.7%
Income Tax Expense (Benefit) 17.2M USD -1.96%
Net Income (Loss) Attributable to Parent 11.9M USD -47.6%
Earnings Per Share, Basic 0.86 USD/shares -52.7%
Earnings Per Share, Diluted 0.89 USD/shares -49.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.4M USD -58%
Accounts Receivable, after Allowance for Credit Loss, Current 115M USD +34%
Inventory, Net 42.5M USD -26.4%
Other Assets, Current 3.82M USD +31.6%
Assets, Current 187M USD -3.71%
Deferred Income Tax Assets, Net 30.7M USD +32.1%
Property, Plant and Equipment, Net 1.01M USD -30.6%
Intangible Assets, Net (Excluding Goodwill) 107M USD -4.51%
Goodwill 45M USD +4.59%
Other Assets, Noncurrent 33.4M USD +373%
Assets 405M USD +6.04%
Accounts Payable, Current 15.8M USD -20.7%
Accrued Liabilities, Current 73.2M USD +15.4%
Liabilities, Current 86.6M USD -20.5%
Deferred Income Tax Liabilities, Net 4.54M USD
Operating Lease, Liability, Noncurrent 839K USD -62.8%
Other Liabilities, Noncurrent 4.26M USD +88.7%
Liabilities 153M USD +6.27%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.11M USD -149%
Retained Earnings (Accumulated Deficit) 122M USD +10.8%
Stockholders' Equity Attributable to Parent 252M USD +5.91%
Liabilities and Equity 405M USD +6.04%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.5M USD -102%
Net Cash Provided by (Used in) Financing Activities 12.6M USD
Net Cash Provided by (Used in) Investing Activities -12.6M USD -7375%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 17.6M shares +0.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -33.4M USD -18.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.4M USD -58%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.32M USD +397%
Deferred Tax Assets, Valuation Allowance 35.1M USD +608%
Deferred Tax Assets, Gross 81.6M USD +220%
Operating Lease, Liability 2.26M USD -39.4%
Depreciation 110K USD -37.9%
Payments to Acquire Property, Plant, and Equipment 58K USD -65.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 8.56M USD -67.1%
Lessee, Operating Lease, Liability, to be Paid 2.37M USD -41.1%
Property, Plant and Equipment, Gross 7.83M USD +0.95%
Operating Lease, Liability, Current 1.42M USD -3.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 413K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.12M USD -32.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 165K USD +42.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 47M USD +2907%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.5M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 421K USD +12.3%
Additional Paid in Capital 374M USD +4.31%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20M USD +423%
Depreciation, Depletion and Amortization 446K USD -41.6%
Share-based Payment Arrangement, Expense 16.5M USD -6.12%
Interest Expense 6.09M USD +256%